Home / Business and Economy / Pharma Giants Face Pipeline Challenge
Pharma Giants Face Pipeline Challenge
29 Jan
Summary
- Pharmaceutical companies may see significant revenue drops.
- New drug development or acquisition is crucial for future growth.
- Up to 19 new medicines could be launched by the end of the decade.
Pharmaceutical companies are facing a critical juncture where their future revenue streams are at risk unless pipelines are replenished. This situation demands a proactive approach, either through internal innovation or the acquisition of new drug candidates.
Despite these headwinds, company leadership remains confident in their growth prospects. Significant progress has been reported in late-stage drug development, with projections indicating up to 19 new medicines could be launched by the end of the current decade.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
